Outcomes When Switching From a Pro Re Nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration
Ophthalmologica - Switzerland
doi 10.1159/000452929
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
S. Karger AG